Hemogenyx secures clearance for pediatric enrolment in leukemia trial
(Alliance News) - Hemogenyx Pharmaceuticals PLC on Monday said it has received clearance to begin pediatric enrolment in its phase 1 trial of a leukemia treatment. Read More
| Price | 596.00p on 26-12-2025 at 05:12:24 |
|---|---|
| Change | 0.00p 0% |
| Buy | 622.00p |
| Sell | 580.00p |
| Last Trade: | Buy 19.00 at 596.00p |
| Day's Volume: | 0 |
| Last Close: | 596.00p |
| Open: | 0.00p |
| ISIN: | GB00BQVXM815 |
| Day's Range | 0.00p - 0.00p |
| 52wk Range: | 124.50p - 1,790.00p |
| Market Capitalisation: | £36.01m |
| VWAP: | 0.00p |
| Shares in Issue: | 6.04m |
Sector: Medicine and Biotech
Hemogenyx Pharmaceuticals (HEMO) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 19 | 596.00p | Suspected BUY Trade |
12:35:17 - 24-Dec-25 |
| Buy* | 15 | 603.00p | Ordinary |
12:29:41 - 24-Dec-25 |
| Unknown* | 0 | 622.00p | SI Trade |
12:06:42 - 24-Dec-25 |
| Buy* | 8 | 603.00p | Ordinary |
11:45:06 - 24-Dec-25 |
| Sell* | 318 | 594.40p | Ordinary |
11:30:57 - 24-Dec-25 |
| Sell* | 260 | 578.6253p | Ordinary |
11:00:21 - 24-Dec-25 |
| Sell* | 2 | 576.00p | SI Trade |
10:52:49 - 24-Dec-25 |
| Buy* | 5 | 605.00p | Ordinary |
09:47:56 - 24-Dec-25 |
| Buy* | 14 | 605.00p | Ordinary |
09:31:47 - 24-Dec-25 |
| Sell* | 1 | 574.00p | SI Trade |
09:31:28 - 24-Dec-25 |
Hemogenyx Pharmaceuticals (HEMO) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 22nd Dec 2025 8:00 am | RNS | Update on Admission of Shares |
| 18th Dec 2025 7:00 am | RNS | Issue of Equity |
| 8th Dec 2025 12:48 pm | RNS | Holding(s) in Company |
| 28th Nov 2025 7:00 am | RNS | Total Voting Rights |
| 19th Nov 2025 11:47 am | RNS | Publication of Prospectus |
| 29th Oct 2025 7:00 am | RNS | Clinical Trial Update and Grant of Share Awards |
| 6th Oct 2025 7:00 am | RNS | Clearance to Initiate Pediatric Enrolment |
| 30th Sep 2025 7:00 am | RNS | Half-year Report |
| 30th Sep 2025 7:00 am | RNS | Total Voting Rights |
| 23rd Sep 2025 7:00 am | RNS | Hemogenyx Signs Letter of Intent |